Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-cell Lymphoma (Not Otherwise Specified)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Early research (Phase 1)Not Yet RecruitingNCT07278856
What this trial is testing

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

Who this might be right for
Follicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeFollicular Helper T-Cell Lymphoma, Follicular-Type+3 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT04251065
What this trial is testing

Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH

Who this might be right for
Refractory T-Cell LymphomaRelapsed T-Cell Lymphoma
Fondazione Italiana Linfomi - ETS 8
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Not applicableActive Not RecruitingNCT01787409
What this trial is testing

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more
Mayo Clinic 565
Not applicableUnknownNCT05821192
What this trial is testing

Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma
Ou Bai, MD/PHD 34
Testing effectiveness (Phase 2)Study completedNCT02561273
What this trial is testing

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell Lymphoma+7 more
University of Nebraska 54
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Early research (Phase 1)Looking for participantsNCT06508463
What this trial is testing

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified+4 more
Mayo Clinic 21
Large-scale testing (Phase 3)Looking for participantsNCT06561048
What this trial is testing

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc. 150
Post-approval studies (Phase 4)UnknownNCT01746992
What this trial is testing

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Who this might be right for
ALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell Lymphoma+3 more
Ruijin Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03590574
What this trial is testing

Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

Who this might be right for
T Cell Non-Hodgkin LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma+1 more
Autolus Limited 20
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Testing effectiveness (Phase 2)Ended earlyNCT03552692
What this trial is testing

Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma

Who this might be right for
T-Cell Lymphoma RelapsedT-Cell Lymphoma Refractory
Fondazione Italiana Linfomi - ETS 22
Testing effectiveness (Phase 2)WithdrawnNCT04795869
What this trial is testing

Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma

Who this might be right for
Recurrent Angioimmunoblastic T-Cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Follicular T-Cell Lymphoma+11 more
Northwestern University
Early research (Phase 1)Study completedNCT00697346
What this trial is testing

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Who this might be right for
B-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more
Millennium Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07293403
What this trial is testing

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Who this might be right for
Follicular Helper T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified
City of Hope Medical Center 25
Early research (Phase 1)Looking for participantsNCT03017820
What this trial is testing

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaHistiocytic and Dendritic Cell NeoplasmMyelodysplastic Syndrome+16 more
Mayo Clinic 127
Not applicableLooking for participantsNCT05978141
What this trial is testing

A Registry for People With T-cell Lymphoma

Who this might be right for
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more
Memorial Sloan Kettering Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT04074746
What this trial is testing

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Classic Hodgkin Lymphoma+7 more
M.D. Anderson Cancer Center 45
Load More Results
294